Researchers Identify Unique Adult Stem Cells
Tags: STEM cells -- Research; LOSORDO, Douglas; TISSUES; CELLULAR therapy; ORGANOTHERAPY
Related Articles
- Efficient Isolation of Cardiac Stem Cells from Brown Adipose. Zhiqiang Liu; Haibin Wang; Ye Zhang; Jin Zhou; Qiuxia Lin; Yanmeng Wang; Cuimi Duan; Kuiwu Wu; Changyong Wang // Journal of Biomedicine & Biotechnology;2010, p1
Cardiac stem cells represent a logical cell type to exploit in cardiac regeneration. The efficient harvest of cardiac stem cells from a suitable source would turn promising in cardiac stem cell therapy. Brown adipose was recently found to be a new source of cardiac stem cells, instrumental to...
- Editorial: Cell therapy - When will it deliver its promise? Cubitt, Iain // Journal of Commercial Biotechnology;Autumn2001, Vol. 8 Issue 2, p93
Editorial. Presents comments and observations on stem cell research in the U.S. Questions in cell therapies based in human cells raised by the subject; Ethical issues in the use of human fetal-derived neural cells; Information on stem cells.
- Technique of cultivating limbal derived corneal epithelium on human amniotic membrane for clinical transplantation. Fatima, A.; Sangwan, V. S.; Iftekhar, G.; Reddy, P.; Matalia, H.; Balasubramanian, D.; Vemuganti, G. K. // Journal of Postgraduate Medicine;Oct-Dec2006, Vol. 52 Issue 4, p257
Background: The technique of transplantation of cultivated limbal epithelium rather than direct limbal tissue is a novel method of "cell therapy" involved in reconstructing the ocular surface in severe limbal stem cell deficiency [LSCD], caused by chemical burns. Aim: To describe a simple...
- Umbilical Cord Blood: A Unique Source of Pluripotent Stem Cells for Regenerative Medicine. Harris, David T.; Rogers, Ian // Current Stem Cell Research & Therapy;Dec2007, Vol. 2 Issue 4, p301
It is estimated that almost 1 in 3 individuals in the United States might benefit from regenerative medicine therapy. Unfortunately, embryonic stem (ES) cell therapies are currently limited by ethical, political, biological and regulatory hurdles. Thus, for the foreseeable future, the march of...
- New cell harvesting system 'more efficient' Isolagen says. // Dermatology Times;Jul2005, Vol. 26 Issue 7, p20
The article reports that Isolagen Inc., which specializes in the development and commercialization of autologous cellular therapies for tissue regeneration, has designed an automated cellular expansion system to propagate and harvest cells more efficiently and cost-effectively than other cell...
- Biosafety Considerations for Cell-based Therapies. Weber, Darin J. // BioPharm International;Jul2004, Vol. 17 Issue 7, p48
Investigates the safety considerations for cell-based therapies. Assessing risks in living cells; Elements of a biosafety programs; Qualifications of materials used in product manufacturing; Final product release testing; Preclinical pharmacology and toxicology.
- Monitoring Cell Therapy Using Iron Oxide MR Contrast Agents. M. Bulte, Jeff W.; Kraitchman, Dara L. // Current Pharmaceutical Biotechnology;Dec2004, Vol. 5 Issue 6, p567
Given the remarkable progress that has recently been obtained in animal studies, the clinical use of stem and progenitor cells to correct or replace defective cell populations may soon become a reality. In order to develop effective cell therapies, the location and distribution of these cells...
- STEM CELL ENHANCEMENT. Geddes, Linda // New Scientist;6/16/2007, Vol. 194 Issue 2608, p15
The article discusses the difficulties that doctors and scientists are having with regenerative medicine and stem cells. They are finding that they cannot control what the adult stem cells do once they enter another body. Now researchers are thinking that genetically modified stem cells might...
- CIRM Loan to Boost Diabetes Research. Chambers, Heather // San Diego Business Journal;11/9/2009, Vol. 30 Issue 45, p1
No abstract available.
